In the present study, we attempted to comprehensively screen shared neoantigens derived from recurrent somatic mutations observed in 10,182 exome sequencing data in the Cancer Genome Atlas (TCGA) and identified a peptide derived from FGFR3 Y373C, which is frequent in bladder cancer, as a candidate of shared neoantigens. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.